Omalizumabe na UCE: Indicação e Condução episode artwork

EPISODE · Nov 4, 2021 · 12 MIN

Omalizumabe na UCE: Indicação e Condução

from ASBAI · host ASBAI

Os medicamentos imunobiológicos mudaram a forma de tratar, trazendo mais qualidade de vida aos paciente. Esse é o caso do omalizumabe, indicado para a urticária crônica espontânea. O Dr. Luis Felipe Ensina, Coordenador do Departamento Científico de Urticária da ASBAI, traz mais informações neste episódio. Site: www.asbai.org.br Instagram: @asbai_alergia Facebook: asbai.alergia Twitter: @asbai_alergia YouTube: ASBAIAlergia

Episode metadata supplied by the publisher feed · Published Nov 4, 2021

Embed this episode

NOW PLAYING

Omalizumabe na UCE: Indicação e Condução

0:00 12:22

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of ASBAI?

This episode is 12 minutes long.

When was this ASBAI episode published?

This episode was published on November 4, 2021.

Can I download this ASBAI episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!